SEC
SlamSEC
SearchBrowseEarnings

ROCKWELL MEDICAL, INC.

Nasdaq:RMTI
Pharmaceutical Preparations·WIXOM, MI
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

Summary Financials

Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).

CEO
Strobeck Mark
CFO
Neri Jesse
Revenue
$83.6M
+14.8% YoY
FY 2024
Adj. EBITDA
-$5.2M
-6.3% margin
FY 2024
Net Income
-$8.4M
-10.1% margin
FY 2024
EPS (Diluted)
-$0.37
FY 2024
Stock Price
$0.90
-0.1%
2026-03-13
52W Range
$0.78 – $2.10
P/E Ratio
-2.4x
Market Cap
$35.3M
Cash
$9.0M
FY 2024
Total Debt
$8.3M
FY 2024
Net Cash
$690,000
FY 2024
Enterprise Value
$34.6M
Debt / EBITDA
0.1x
FY 2024
EV / EBITDA
-6.6x
Employees
300
FY 2024